Given the known interaction between ethnicity and AL incidence, we sought for the first time, to better understand the epidemiological patterns of AL distribution throughout Florida. Utilizing the Florida Cancer Data System (FCDS), we analyzed the patterns of B-cell ALL, T-cell ALL, non-APL AML and APL AML among Hispanics and non Hispanic Whites.
Cancer incidence data were obtained from the FCDS from 2004 to 2013. The FCDS is a cancer registry for the entire state of Florida, and a member of the National Program of Cancer Registries administered the Centers for Disease Control and Prevention (CDC). FCDS data collection practices are described elsewhere. 7 Inclusion criteria for this study included all patients over the age of 20, Florida residents, identified as White or Hispanic of any race, and diagnosed with of B-cell ALL, T-cell ALL, non-APL AML and APL AML, utilizing the International Classification of Diseases for Oncology 3rd Edition histology codes. B-Cell ALL is defined as histologic codes 9727, 9728, 9835, 9836, T-cell ALL is defined as 9729, 9837, non-APL AML is defined as 9840, 9861, 9867, 9870, 9871,9872, 9873, 9874, 9891, 9895, 9896, 9897, 9910, 9920, 9930, 9931 and APL is defined as 9866. These four leukemias were chosen for analysis given previous research on the association of race and ethnicity with each and the differing clinical aspects of each. Population estimates, separated by race/ ethnicity, were obtained from the 2010 SF1 100% census data. Age-adjusted IR and incidence rate ratios (IRR), per 100 000, were adjusted to the 2000 standard US million population. The 95% confidence intervals were calculated for IR and IRR using the normal approximation. Age was categorized in 15-year age groups. Table 1 summarizes the IR as well as the IRR of ALL (both B-and T-cell ALL) and AML (APL and non-APL cases) in both non Hispanic whites and Hispanics. Similarly in Table 1 , IR and IRRs are presented for these AL subtypes for both US-born and non-US-born Hispanics. Our results agree with previous reports, where Hispanics have higher rates of B-ALL compared with non Hispanic whites. Hispanics also had comparatively higher rates of APL and unlike previous reports; AML, in general, was more common in Hispanics (regardless of subtype). Also in agreement with other reports, T-cell ALL was less common in Hispanic patients. Our nativity analysis confirmed no significant difference in AL distribution between US-born and foreign-born Hispanics. Finally, to assess the effects of age on these findings, the age distribution of AL by 15-year increments is presented in Table 2 . Because prognosis and treatment outcomes differ significantly between adult and pediatric patients, and because nativity analyses including children have the potential for age-related bias, we restricted our study to an adult population. The age distribution trends in Table 2 reflect what is typically known about the IR of AL in adult patients.
The lack of population-based studies in AL relate to a large degree on the rarity of these diseases when compared with other tumor types. Nonetheless, when compared with similar reports analyzing the population distribution of AL in large populations. 8 Our findings are in general agreement. We noticed, however, that AML was generally more common in Hispanics compared with non Hispanic whites, regardless of subtype. Typically, other studies have reported that APL is more common in Hispanics but that the incidence of AML is less common overall, when compared with whites. 6, 8 In a California analysis, it was noted that 84% of Hispanics in that state are of Mexican origin. 8 In our analysis, Hispanics of Mexican descent were a minority group, which may explain, in part, this new finding. In agreement with others, 8, 9 lack of a nativity difference implies that host susceptibility factors are critical determinants of disease pathogenesis in the case of AL. For example, Douer et al. 10 showed that a specific break-point variant (bcr-1) of the driver chimeric fusion gene in APL was more common in Hispanics than non-Hispanics. Similarly, singlenucleotide polymorphisms in the GATA3 gene appear more common in Hispanics with B-ALL compared with other groups. 11 Several other so-called 'risk alleles' including ARID5B, CDKN2A and CEBPE have also been found more commonly in Hispanic B-ALL. 12 The interaction between environmental factors and these host susceptibility factors in the pathogenesis of AL is very much, Letter to the Editor unchartered territory. Several environmental modifiers have been implicated and include infectious agents (viruses mainly), ionizing radiation, herbicides, embalming fluids, ethylene oxides and smoking. 13, 14 As we observed no effect from nativity in our analysis, it is difficult to implicate specific environmental factors that might contribute directly to the onset of AL in this adult population. We acknowledge, of course, that t he age at immigration could impact on non-American environmental exposures however; this data were not available in our analysis.
AL is a medical emergency, early diagnosis and treatment heavily influence outcome. In Hispanic children with B-ALL, poorer socioeconomic status clearly influences overall survival.
14 There are limited data relating socioeconomic status to survival in adults with AL. Overall, almost a quarter of Hispanics live in poverty in the United States. 15 Most of these will be uninsured. Older Hispanic patients, particularly, are less likely to have health insurance when compared with non Hispanic white patients (44.6% vs 25.7%, respectively). In South Florida, 33% of Hispanics are uninsured and a significant poverty disparity exits (19% vs 12% for non Hispanic whites). These factors can contribute to poorer outcome in Hispanic populations.
In conclusion, we report a higher incidence rate of B-ALL for Hispanics in Florida. In addition, we also noted that AML (regardless of subtype) was more common in Floridian Hispanics. The absence of a nativity difference in accounting for variation in IR implies that heritable factors are key determinants of disease pathogenesis.
